Aclarion, Inc. (ACONW)

Market Cap	3.42M
Revenue (ttm)	67,483
Net Income (ttm)	-7.39M
Shares Out	671.37K
EPS (ttm)	-12.69
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,398
Open	0.0427
Previous Close	0.0395
Day's Range	0.0427 - 0.0447
52-Week Range	0.0122 - 0.2446
Beta	1.45
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2025

About ACONW

Aclarion, Inc. operates as a healthcare technology company in the United States. The company uses magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. It develops NOCISCAN, which uses MRS capabilities to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The company also provides NOCISCAN MRS Exam Protocol, a custom software protocol for using commercially available MRS pulse sequences in scanning intervertebral discs which extends the time of a standard lumbar MRI exam;...

• Industry: Medical - Healthcare Information Services
• Sector: Healthcare
• Founded: 2008
• Employees: 6
• Stock Exchange: NASDAQ
• Ticker Symbol: ACONW
• Website: https://www.aclarion.com